NextCell Pharma AB (STO:NXTCL)
Sweden · Delayed Price · Currency is SEK 1.266
-0.030 (-2.31%)
At close: Mar 27, 2026
NextCell Pharma AB Market Cap
NextCell Pharma AB has a market cap or net worth of 141.02 million as of March 27, 2026. Its market cap has decreased by -39.33% in one year.
Market Cap
141.02M
Enterprise Value
114.99M
Revenue
9.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.27
Market Cap Chart
Since July 13, 2017, NextCell Pharma AB's market cap has increased from 33.03M to 141.02M, an increase of 327.01%. That is a compound annual growth rate of 18.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 141.02M | 73.19% |
| Dec 30, 2025 | 81.43M | -60.77% |
| Dec 30, 2024 | 207.58M | 129.58% |
| Dec 29, 2023 | 90.42M | -62.64% |
| Dec 30, 2022 | 242.03M | -9.28% |
| Dec 30, 2021 | 266.79M | -35.76% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jul 13, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Initiator Pharma | 205.36M |
| AlzeCure Pharma AB | 193.06M |
| Isofol Medical AB | 185.25M |
| Simris Group AB (PUBL) | 133.63M |
| IRLAB Therapeutics AB | 128.26M |
| Xbrane Biopharma AB | 124.15M |
| Active Biotech AB | 114.67M |
| Alligator Bioscience AB | 106.53M |